TNFSF10 and neoplasm: To further optimize the treatment efficiency of TRAIL-based cancer drugs, targeting concepts have been evaluated which serve two main purposes: 1) to accumulate the drugs at the tumor site and thereby limiting sequestration by non-transformed host cells (reduced side-effects) and 2) to immobilize TRAIL to the cancer cell membrane which converts a soluble drug into a membrane-bound analog.